NeuroScienfitic Biopharmaceuticals Investor Briefing – 10 June
NeuroScienfitic Biopharmaceuticals (ASX: NSB) Webcast Replay
NeuroScienfitic Biopharmaceuticals Ltd (ASX: NSB) is a drug development company focused on developing novel peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.
As a part of our ‘Meet the CEOs’ series, CEO Matthew Liddelow provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 10th June 2020 at 12pm (AEST).